Active Ingredient: BUDESONIDE
Proprietary Name: EOHILIA
Dosage Form; Route of Administration: SUSPENSION; ORAL
Strength: 2MG/10ML
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code:
Application Number: N213976
Product Number: 001
Approval Date: Feb 9, 2024
Applicant Holder Full Name: TAKEDA PHARMACEUTICALS USA INC
Marketing Status:
Prescription
Patent and Exclusivity Information